GPhA’s New VP-Regulatory Sciences Has Expertise In Generic Injectable Business
This article was originally published in The Pink Sheet Daily
Executive Summary
During nine years at Ben Venue, Gaugh was responsible for strategic planning, financial management, business development, marketing and sales for the company’s $500 million branded generic injectable business, which is now struggling with manufacturing challenges.